Acute Bronchiolitis Clinical Trial
Official title:
Comparison of High Flow Nasal Cannula and Standard Face Mask Oxygen Therapy in Children With Moderate and Severe Bronchiolitis; a Randomized Controlled Trial
The study aims to compare the efficacy of two different oxygenation methods on decrease respiratory rate, heart rate, and clinical respiratory score in children with moderate to severe bronchiolitis requiring oxygen therapy. 1. Standard face mask oxygen therapy (St-FMOT) 2. High-flow nasal cannula oxygen therapy (HFNCOT)
Bronchiolitis is the most common cause of hospitalization for children under one year of age and, caused by respiratory viruses. Although several medications and interventions studied for bronchiolitis treatment, hydration and oxygenation are the main treatments. High-flow nasal cannula oxygen therapy (HFNCOT) has been widely used to provide respiratory support in children with acute respiratory diseases. Patients had earlier improvement with HFNCOT to decrease the respiratory rate and respiratory effort than patients with standard low-flow oxygen therapy (SOT). HFNCOT therapy reduced more effective in heart rate, respiratory effort, and length of supportive oxygen treatment (LOOT) compared with SOT. However, the length of hospital stay (LOS) and feeding ability had better consequences in patients with moderate and severe bronchiolitis treated with HFNCOT. Another published study shows that in infants with acute bronchiolitis, which required oxygen therapy, there was no significant difference between therapy groups in terms of LOOT, LOS, and admission to the intensive care unit (ICU). HFNCOT was more efficient than SOT and reduced the rate of intubation/invasive ventilation in severe bronchiolitis management. Despite these beneficial effects of HFNCOT, it was not recommended by international guidelines yet. However, well designed, prospective randomized controlled trials are still needed to use this therapy in the wards. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01469845 -
The SABRE Trial of Hypertonic Saline in Acute Bronchiolitis
|
Phase 3 | |
| Completed |
NCT02962505 -
Continuous Regional Analysis Device for Neonate Lung
|
||
| Recruiting |
NCT02984046 -
Acute Bronchiolitis and Severity Markers: Interest in Protein CC16
|
N/A | |
| Completed |
NCT01875757 -
Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life
|
Phase 3 | |
| Completed |
NCT01871857 -
7% Hypertonic Saline for Acute Bronchiolitis
|
Phase 4 | |
| Completed |
NCT06139029 -
Comparison of 3% Normal Saline Nebulization Versus Steroid Nebulization in the Treatment of Bronchiolitis
|
Early Phase 1 | |
| Not yet recruiting |
NCT03915197 -
Acute Bronchiolitis in Infants and Allergic Asthma
|
N/A | |
| Completed |
NCT03171142 -
Effect of Heliox on RSV Bronchiolitis
|
Phase 3 | |
| Recruiting |
NCT02093715 -
FeNO and Cytokines in Respiratory Syncytial Virus (RSV) and Non RSV Bronchiolitis in Relation to Future Asthma
|
N/A | |
| Not yet recruiting |
NCT03880903 -
Hypertonic Saline Inhalation in Acute Bronchiolitis
|
Phase 4 | |
| Completed |
NCT04748159 -
Effects of Prone Positioning on Vital Parameters in Infants With Acute Bronchiolitis
|
N/A | |
| Active, not recruiting |
NCT04613180 -
Evaluation of the Effectiveness of Montelukast in Children With Recurrent Obstructive Bronchitis
|
Phase 4 | |
| Recruiting |
NCT06321133 -
High Flow Nasal Cannula Weaning in Acute Bronchiolitis
|
N/A | |
| Completed |
NCT02029040 -
Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis
|
N/A | |
| Recruiting |
NCT03753802 -
Evaluation of the Effects of Respiratory Physiotherapy in Infants With Moderate Acute Bronchiolitis
|
N/A | |
| Withdrawn |
NCT01660867 -
Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis in the Emergency Department
|
Phase 4 |